ArticleEndocrine-related cancer2012

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways.

Su Jung Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.